Dr. Karl Ljungberg has an extensive experience of immunology, virology and particularly vaccinology from Karolinska Institutet, University of North Carolina and Public Health Agency of Sweden. Dr. Ljungberg holds a M.Sc. in Molecular Biology from Stockholm University and a Ph.D. in Infectious Disease Control from Karolinska Institutet.
Sandra Jeldes Granstrand, Director of CMC Development, Chemistry Manufacturing and Control, graduated as Master of Engineering, specialized in Bio-Medical Technology. Previously Deputy Head of Laboratory and CMC at Newron.
Dr. Hans Arwidsson, President, CEO and Board Director, is an executive with broad cross-functional experience from the pharmaceutical industry, e.g. Astra and AstraZeneca. Arwidsson holds a M.Sc. and a Ph.D. in pharmaceutical sciences from Uppsala University as well as an Executive MBA from Stockholm School of Economics.